Abingdon Health Plc (LON:ABDX – Get Free Report) shares were down 0.5% during trading on Thursday . The company traded as low as GBX 10.50 and last traded at GBX 10.69. 57,255 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 250,836 shares. The stock had previously closed at GBX 10.75.
Abingdon Health Trading Down 2.6%
The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The stock has a market capitalization of £26.90 million, a PE ratio of -13.23 and a beta of 0.13. The stock has a 50-day moving average price of GBX 10.35 and a two-hundred day moving average price of GBX 9.68.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Read More
- Five stocks we like better than Abingdon Health
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
